Cargando…
A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693436/ https://www.ncbi.nlm.nih.gov/pubmed/23329595 http://dx.doi.org/10.1007/s40273-012-0003-8 |
_version_ | 1782274726520946688 |
---|---|
author | Allen, Rachel Brainsky, Andres Grotzinger, Kelly Roccia, Tito |
author_facet | Allen, Rachel Brainsky, Andres Grotzinger, Kelly Roccia, Tito |
author_sort | Allen, Rachel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3693436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer International Publishing AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-36934362013-07-15 A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” Allen, Rachel Brainsky, Andres Grotzinger, Kelly Roccia, Tito Pharmacoeconomics Correspondence Springer International Publishing AG 2012-11-23 2013 /pmc/articles/PMC3693436/ /pubmed/23329595 http://dx.doi.org/10.1007/s40273-012-0003-8 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Correspondence Allen, Rachel Brainsky, Andres Grotzinger, Kelly Roccia, Tito A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title | A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title_full | A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title_fullStr | A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title_full_unstemmed | A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title_short | A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” |
title_sort | comment on boyers et al.: “eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a nice single technology appraisal” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693436/ https://www.ncbi.nlm.nih.gov/pubmed/23329595 http://dx.doi.org/10.1007/s40273-012-0003-8 |
work_keys_str_mv | AT allenrachel acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT brainskyandres acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT grotzingerkelly acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT rocciatito acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT allenrachel commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT brainskyandres commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT grotzingerkelly commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal AT rocciatito commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal |